Diffusion Weighted Imaging in Prostate Cancer

Overview

Journal Eur Radiol

Specialty Radiology

Date 2010 Oct 12

PMID 20936413

Citations 29

Authors

Cher Heng Tan

Jihong Wang

Vikas Kundra

Affiliations

Soon will be listed here.

Abstract

Diffusion-weighted imaging has generated substantial interest in the hope that it can be developed into a robust technique to improve the accuracy of MRI for the evaluation of prostate cancer. This technique has the advantages of short acquisition times, no need for intravenous administration of contrast medium, and the ability to study diffusion of water molecules that indirectly reflects tissue cellularity. In this article, we review the existing literature on the utility of DWI in tumour detection, localisation, treatment response, limitations of the technique, how it compares with other imaging techniques, technical considerations and future directions.

Citing Articles

Tumor Area Highlighting Using T2WI, ADC Map, and DWI Sequence Fusion on bpMRI Images for Better Prostate Cancer Diagnosis.

Teica R, Serbanescu M, Florescu L, Gheonea I Life (Basel). 2023; 13(4).

PMID: 37109440 PMC: 10146015. DOI: 10.3390/life13040910.

A valuable MRI examination method for prostate cancer screening.

Yang X, Shan L, Cao H, Jiang X, Ma X Medicine (Baltimore). 2020; 99(48):e23134.

PMID: 33235074 PMC: 7710172. DOI: 10.1097/MD.0000000000023134.

Locally advanced prostate cancer imaging findings and implications for treatment from the surgical perspective.

Elsherif S, Kuchana V, Aslam R, Kamat A, Bhosale P, Klekers A Abdom Radiol (NY). 2019; 45(3):865-877.

PMID: 31724081 DOI: 10.1007/s00261-019-02318-3.

The Role of Lactate Metabolism in Prostate Cancer Progression and Metastases Revealed by Dual-Agent Hyperpolarized C MRSI.

Bok R, Lee J, Sriram R, Keshari K, Sukumar S, Daneshmandi S Cancers (Basel). 2019; 11(2).

PMID: 30813322 PMC: 6406929. DOI: 10.3390/cancers11020257.

Deep Learning Role in Early Diagnosis of Prostate Cancer.

Reda I, Khalil A, Elmogy M, Abou El-Fetouh A, Shalaby A, Abou El-Ghar M Technol Cancer Res Treat. 2018; 17:1533034618775530.

PMID: 29804518 PMC: 5972199. DOI: 10.1177/1533034618775530.

References

Kajihara H, Hayashida Y, Murakami R, Katahira K, Nishimura R, Hamada Y . Usefulness of diffusion-weighted imaging in the localization of prostate cancer. Int J Radiat Oncol Biol Phys. 2008; 74(2):399-403. DOI: 10.1016/j.ijrobp.2008.08.017. View

Engelbrecht M, Huisman H, Laheij R, Jager G, van Leenders G, Hulsbergen-van de Kaa C . Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology. 2003; 229(1):248-54. DOI: 10.1148/radiol.2291020200. View

Xu J, Humphrey P, Kibel A, Snyder A, Narra V, Ackerman J . Magnetic resonance diffusion characteristics of histologically defined prostate cancer in humans. Magn Reson Med. 2009; 61(4):842-50. PMC: 3080096. DOI: 10.1002/mrm.21896. View

Rouviere O, Mege-Lechevallier F, Chapelon J, Gelet A, Bouvier R, Boutitie F . Evaluation of color Doppler in guiding prostate biopsy after HIFU ablation. Eur Urol. 2006; 50(3):490-7. DOI: 10.1016/j.eururo.2005.12.046. View

Miao H, Fukatsu H, Ishigaki T . Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. Eur J Radiol. 2006; 61(2):297-302. DOI: 10.1016/j.ejrad.2006.10.002. View

Lim H, Kim J, Kim K, Cho K . Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study. Radiology. 2008; 250(1):145-51. DOI: 10.1148/radiol.2501080207. View

Chen M, Dang H, Wang J, Zhou C, Li S, Wang W . Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined. Acta Radiol. 2008; 49(5):602-10. DOI: 10.1080/02841850802004983. View

Mullerad M, Hricak H, Kuroiwa K, Pucar D, Chen H, Kattan M . Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol. 2005; 174(6):2158-63. DOI: 10.1097/01.ju.0000181224.95276.82. View

Kim C, Choi D, Park B, Kwon G, Lim H . Diffusion-weighted MR imaging for the evaluation of seminal vesicle invasion in prostate cancer: initial results. J Magn Reson Imaging. 2008; 28(4):963-9. DOI: 10.1002/jmri.21531. View

10.

Kitajima K, Kaji Y, Kuroda K, Sugimura K . High b-value diffusion-weighted imaging in normal and malignant peripheral zone tissue of the prostate: effect of signal-to-noise ratio. Magn Reson Med Sci. 2008; 7(2):93-9. DOI: 10.2463/mrms.7.93. View

11.

Kumar V, Jagannathan N, Kumar R, Das S, Jindal L, Thulkar S . Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level. Magn Reson Imaging. 2006; 24(5):541-8. DOI: 10.1016/j.mri.2006.01.001. View

12.

Kitajima K, Kaji Y, Fukabori Y, Yoshida K, Suganuma N, Sugimura K . Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging. J Magn Reson Imaging. 2010; 31(3):625-31. DOI: 10.1002/jmri.22075. View

13.

Bilgili Y, Unal B . Effect of region of interest on interobserver variance in apparent diffusion coefficient measures. AJNR Am J Neuroradiol. 2004; 25(1):108-11. PMC: 7974154. View

14.

DiBiase S, Hosseinzadeh K, Gullapalli R, Jacobs S, Naslund M, Sklar G . Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2002; 52(2):429-38. DOI: 10.1016/s0360-3016(01)02609-8. View

15.

Gibbs P, Pickles M, Turnbull L . Diffusion imaging of the prostate at 3.0 tesla. Invest Radiol. 2006; 41(2):185-8. DOI: 10.1097/01.rli.0000192418.30684.14. View

16.

Pouliot J, Kim Y, Lessard E, Hsu I, Vigneron D, Kurhanewicz J . Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging. Int J Radiat Oncol Biol Phys. 2004; 59(4):1196-207. DOI: 10.1016/j.ijrobp.2004.02.055. View

17.

deSouza N, Riches S, Vanas N, Morgan V, Ashley S, Fisher C . Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. Clin Radiol. 2008; 63(7):774-82. DOI: 10.1016/j.crad.2008.02.001. View

18.

Ren J, Huan Y, Wang H, Ge Y, Chang Y, Yin H . Seminal vesicle invasion in prostate cancer: prediction with combined T2-weighted and diffusion-weighted MR imaging. Eur Radiol. 2009; 19(10):2481-6. DOI: 10.1007/s00330-009-1428-0. View

19.

Padhani A, Liu G, Koh D, Chenevert T, Thoeny H, Takahara T . Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia. 2009; 11(2):102-25. PMC: 2631136. DOI: 10.1593/neo.81328. View

20.

DeLano M, Cooper T, Siebert J, Potchen M, Kuppusamy K . High-b-value diffusion-weighted MR imaging of adult brain: image contrast and apparent diffusion coefficient map features. AJNR Am J Neuroradiol. 2000; 21(10):1830-6. PMC: 7974278. View